Petros Pharmaceuticals Inc (PTPI)

Stock price, financials, and technical signals for Petros Pharmaceuticals Inc (PTPI).

Twitter
Facebook
Email
FinancialsNews & SentimentProCandlestick ProbabilityElite

$0.07

-0.003

(-4.17%)

As of 04/03/2025 5:00 PM ET • Disclaimer
Powered by Stocksift.com

100%

PTPI Performance Snapshot

1-Week Chg

-37.84%

1-Month Chg

-31.00%

3-Month Chg

-82.58%

6-Month Chg

-80.29%

1-Year Chg

-92.58%

Year-To-Date Chg

-85.26%

Beta 1-Year

1.49

Beta 5-Year

2.00

Volatility (10-Day)

26.68%

PTPI Technicals

PTPI Financials

Balance Sheet

(USD)

2024 Q3

Y/Y CHANGE

  • Cash and equivalents

    $3.89M

    -78.33%

  • Total assets

    $20.69M

    -46.82%

  • Total liabilities

    $17.58M

    -44.83%

  • Total investments

    $0

    0%

  • Shareholders' equity

    $3.12M

    -55.06%

  • Book value per share

    $0.32

    -90.31%

Income Statement

(USD)

2024 Q3

Y/Y CHANGE

  • Revenue

    $1.58M

    -5.87%

  • Net income

    -$2.22M

    51.19%

  • Operating expense

    $3.63M

    12.78%

  • Gross profit

    $1.29M

    1.83%

  • EBITDA

    -$1.29M

    63.64%

  • Earnings per share

    -$0.53

    100.00%

Cash Flow

(USD)

2024 Q3

Y/Y CHANGE

  • Net change in cash

    -$3.57M

    -133.68%

  • Cash from operations

    -$771.25K

    80.94%

  • Cash from investing

    $0

    0%

  • Cash from financing

    -$2.77M

    -118.97%

  • Free cash flow

    -$771.25K

    80.94%

  • Free cash flow per share

    -$0.08

    95.91%

Metrics

(USD)

2024 Q3

Y/Y CHANGE

  • Market capitalization

    $3.43M

    -6.20%

  • Enterprise value

    $3.60M

    -28.33%

  • Shares outstanding

    9.61M

    354.52%

  • Profit margin

    -332.80%

    -22.49%

  • Gross margin

    81.80%

    8.20%

  • EBITDA margin

    -82.10%

    61.36%

Dividends

(USD)

2024 Q3

Y/Y CHANGE

  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    0.85

    -71.75%

View All Financials